These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 3415215)
1. Comparative pharmacokinetics of tromethamine fosfomycin and calcium fosfomycin in young and elderly adults. Borsa F; Leroy A; Fillastre JP; Godin M; Moulin B Antimicrob Agents Chemother; 1988 Jun; 32(6):938-41. PubMed ID: 3415215 [TBL] [Abstract][Full Text] [Related]
2. Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity. Bergan T Infection; 1990; 18 Suppl 2():S65-9. PubMed ID: 2286464 [TBL] [Abstract][Full Text] [Related]
3. Relative bioavailability of fosfomycin and of trometamol after administration of single dose by oral route of fosfomycin trometamol in fasting conditions and after a meal. Borgia M; Longo A; Lodola E Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):411-7. PubMed ID: 2793277 [TBL] [Abstract][Full Text] [Related]
4. Urinary concentrations of fosfomycin after a single 3 g dose of fosfomycin to elderly nursing-home patients. Janknegt R; Hooymans PM; Fabius GT; Nohlmans-Paulssen MK; Machielsen C; Boogaard-van den Born J; Rang J; Smits CA; Willems-Thissen ME; Krommenhoek A Pharm World Sci; 1994 Jun; 16(3):149-53. PubMed ID: 7920366 [TBL] [Abstract][Full Text] [Related]
5. Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants. Wenzler E; Bleasdale SC; Sikka M; Bunnell KL; Finnemeyer M; Rosenkranz SL; Danziger LH; Rodvold KA; Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891606 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers. Wenzler E; Ellis-Grosse EJ; Rodvold KA Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630194 [TBL] [Abstract][Full Text] [Related]
7. Fosfomycin distribution in the lower urinary tract after administration of fosfomycin trometamol salt. Scaglione F; Cicchetti F; Demartini G; Arcidiacono M Int J Clin Pharmacol Res; 1994; 14(3):107-9. PubMed ID: 7883387 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics of trometamol-fosfomycin in patients with renal insufficiency]. Fillastre JP; Leroy A; Josse S; Moulin B Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):728-30. PubMed ID: 3054756 [TBL] [Abstract][Full Text] [Related]
9. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Patel SS; Balfour JA; Bryson HM Drugs; 1997 Apr; 53(4):637-56. PubMed ID: 9098664 [TBL] [Abstract][Full Text] [Related]
10. Fosfomycin tromethamine: single-dose treatment of acute cystitis. Stein GE Int J Fertil Womens Med; 1999; 44(2):104-9. PubMed ID: 10338268 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of single-dose oral and intramuscular ketorolac tromethamine in the young and elderly. Jallad NS; Garg DC; Martinez JJ; Mroszczak EJ; Weidler DJ J Clin Pharmacol; 1990 Jan; 30(1):76-81. PubMed ID: 2303585 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic comparison between fosfomycin and other phosphonic acid derivatives. Bergan T Chemotherapy; 1990; 36 Suppl 1():10-8. PubMed ID: 2085981 [TBL] [Abstract][Full Text] [Related]